Methods of treating necrotizing enterocolitis by administering nuclear oligomerization domain-2 agonists,TLR9 agonists and TLR4 antagonists
US9549980B2 · kind B2 · utility
2Cited by
27References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 26, 2013 |
| Grant date | Jan 24, 2017 |
| Priority date | — |
| Expiry date | Jan 19, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2896
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.